Emerging Therapeutic Biomarkers in Endometrial Cancer

Emerging Therapeutic Biomarkers in Endometrial Cancer

Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth factor) in endometrial cancer show modest effects, there are still challenges that might remain regarding primary/...

Full description

Bibliographic Details
Main Authors:	Peixin Dong, Masanori Kaneuchi, Yosuke Konno, Hidemichi Watari, Satoko Sudo, Noriaki Sakuragi
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2013/130362

Similar Items

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
by: Sudo Satoko, et al.
Published: (2011-08-01)

Methodological considerations in the analysis of the therapeutic significance of lymphadenectomy in endometrial cancer
by: Yukiharu Todo, et al.
Published: (2013-03-01)

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway
by: Peixin Dong, et al.
Published: (2021-06-01)

PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3
by: Daozhi Xu, et al.
Published: (2020-12-01)

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
by: Peixin Dong, et al.
Published: (2019-07-01)

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
by: Peixin Dong, et al.
Published: (2020-06-01)

Apoptosis and Molecular Targeting Therapy in Cancer
by: Mohamed Hassan, et al.
Published: (2014-01-01)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
by: Peixin Dong, et al.
Published: (2019-02-01)

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1
by: Daozhi Xu, et al.
Published: (2020-03-01)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
by: Peixin Dong, et al.
Published: (2018-07-01)

PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
by: Michiel Remmerie, et al.
Published: (2019-06-01)

Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications
by: Peixin Dong, et al.
Published: (2021-02-01)

MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation
by: Daozhi Xu, et al.
Published: (2019-08-01)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
by: Hassan Mohamed K, et al.
Published: (2011-12-01)

The Emerging Role of the Microenvironment in Endometrial Cancer
by: Subhransu S. Sahoo, et al.
Published: (2018-10-01)

Potential new biomarkers for endometrial cancer
by: Michelle H. Townsend, et al.
Published: (2019-01-01)

Proteomic Biomarkers for the Detection of Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2019-10-01)

Biomarkers as prognostic factors in endometrial cancer.
by: Sławomir J Terlikowski, et al.
Published: (2010-11-01)

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
by: Peixin Dong, et al.
Published: (2017-10-01)

Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
by: Keiko Saotome, et al.
Published: (2021-01-01)

Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection.
by: Mohamed K Hassan, et al.
Published: (2014-01-01)

Novel promising biomarkers in endometrial cancer - review
by: Dominika Krawczyk, et al.
Published: (2019-08-01)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
by: Peixin Dong, et al.
Published: (2018-09-01)

Metformin as a Therapeutic Target in Endometrial Cancers
by: Teresa Y. Lee, et al.
Published: (2018-08-01)

Endometrial Cancer: Molecular and Cellular Basis of Tumor Development, Novel Biomarkers and Therapeutic Agents, and Innovative Research Approaches
by: Donghai Dai, et al.
Published: (2014-01-01)

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
by: Jesus Gonzalez Bosquet, et al.
Published: (2021-01-01)

Circular RNAs: A Promising Biomarker for Endometrial Cancer
by: Guo J, et al.
Published: (2021-02-01)

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2021-02-01)

Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
by: Mohamad Nasir Shafiee, et al.
Published: (2020-07-01)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
by: Daisuke Aoki, et al.
Published: (2013-06-01)

The identification of novel biomarkers to guide treatment in endometrial cancer
by: Kularatne, B. Y.
Published: (2017)

Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.
by: Fabiana Azevedo Voorwald, et al.
Published: (2015-01-01)

Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging
by: Caroline Bouche, et al.
Published: (2020-12-01)

Ornithine decarboxylase as a therapeutic target for endometrial cancer.
by: Hong Im Kim, et al.
Published: (2017-01-01)

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
by: Qi Zhang, et al.
Published: (2017-07-01)

High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
by: John J Wallbillich, et al.
Published: (2017-01-01)

Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer
by: Soukaina Boutriq, et al.
Published: (2021-07-01)

Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer
by: Yaowei Li, et al.
Published: (2020-09-01)

Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2020-11-01)

Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer.
by: Jianpei Li, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_71001nupsorhcfrbjhihfqqleg